Clinical profile of neonatal hyperbilirubinemia in children medical centre Tehran

Masooma Aga; Elmira Haji Esmail Memar; Naseer Yousuf Mir

doi:10.18203/2394-6040.ijcmph20244029

Authors

Masooma Aga Department of Pediatrics, Tehran University of Medical Sciences, Iran
Elmira Haji Esmail Memar Department of Paediatrics, Tehran University of Medical Sciences, Iran
Naseer Yousuf Mir Department of Paediatrics, Government Medical College Handwara, J&K, India

DOI:

https://doi.org/10.18203/2394-6040.ijcmph20244029

Keywords:

Exchange transfusion, Incompatibility, Kernicterus, Neonatal hyperbilirubinemia, Phototherapy

Abstract

Background: Neonatal jaundice is a common finding in newborns especially during the first week of birth. Hyperbilirubinemia in most of the cases is not dangerous and usually results from a physiologic cause. However, due to the capability of unconjugated bilirubin to pass via the blood brain barrier and its neurotoxic effect, proper assessment and management of neonatal jaundice is important for prevention of avoidable neurological complications of NNJ, such as kernicterus.

Methods: This was a descriptive cross-sectional study which studied 220 neonates >34 weeks of GA diagnosed with jaundice admitted in the neonatal ward.

Results: A total of 220 patients with neonatal jaundice were enrolled in the study, 56.8% were male and 43.2% were female. The mean gestational age was 37.56 weeks with 80% of term. The mean birth weight of the study population was 3085.44±540.9 g. The mean total serum bilirubin was 15.908±4.36 mg/dl. In etiology 19.1% were having ABO incompatible, 17.3% were Rh incompatible, 12.7% were IDM, 5.5% were G6PD deficiency, 3% had ABO as well as Rh incompatibility and 0.9% were septic with positive blood culture. Phototherapy (75%) and exchange therapy (5%) was treatment modality during hospitalization.

Conclusions: Neonatal jaundice is an important neonatal condition and needs proper and timely intervention for prevention of avoidable neurological complications. Mostly its physiological but pathological jaundice should also be considered when jaundice appears early or is severe. Intensive phototherapy is most common treatment modality but a significant number needs exchange transfusion.

Metrics

Metrics Loading ...

References

Maisels MJ. Neonatal jaundice. Pediatrics in Review. 2006;27(12):443-54.

Stevenson DK, Vreman HJ, Wong RJ. Bilirubin production and the risk of bilirubin neurotoxicity. In: Seminars in perinatology. WB Saunders. 2011;35(3):121-6.

Cayabyab R, Ramanathan R. High unbound bilirubin for age: a neurotoxin with major effects on the developing brain. Pediatr Res. 2019;85(2):183-90.

Olusanya BO, Teeple S, Kassebaum NJ. The contribution of neonatal jaundice to global child mortality: findings from the GBD 2016 study. Pediatri. 2018;141(2).

Paludetto R, Mansi G, Raimondi F, Romano A, Crivaro V, Bussi M, et al. Moderate hyperbilirubinemia induces a transient alteration of neonatal behavior. Pediatrics. 2002 Oct;110(4):e50.

Lain SJ, Roberts CL, Bowen JR, Nassar N. Early discharge of infants andriskof readmission for jaundice. Pediatrics. 2015;135(2):31421.

Bhutani VK, Stark AR, Lazzeroni LC, Poland R, Gourley GR, Kazmierczak S, et al. Predischarge screening for severe neonatal hyperbilirubinemia identifies infants who need phototherapy. J Pediatr. 2013;162(3):477-82.

Dodd KL. Neonatal jaundice--a lighter touch. Archives of disease in childhood. 1993;68(5 Spec No):529.

Ullah S, Rahman K, Hedayati M. Hyperbilirubinemia in neonates: types, causes, clinical examinations, preventive measures and treatments: a narrative review article. Iran J Publ Heal. 2016;45(5):558.

Gartner LM. Breastfeeding and jaundice. Journal of Perinatology. 2001;21(1):S25-9.

Singh A, Jialal I. Unconjugated Hyperbilirubinemia. In: StatPearls. Treasure Island (FL): StatPearls Publishing; 2021.

Shapiro SM. Bilirubin toxicity in the developing nervous system. Pediatr Neurol. 2003;29(5):410-21.

Porter ML, Dennis BL. Hyperbilirubinemia in the term newborn. Am Fam Physician. 2002;65(4):599-606.

Najib KS, Saki F, Hemmati F, Inaloo S. Incidence, risk factors and causes of severe neonatal hyperbilirubinemia in the South of iran (fars province). Iran Red Crescent Medi J. 2013;15(3):260.

Bujandric N, Grujic J. Exchange Transfusion for Severe Neonatal Hyperbilirubinemia: 17 Years' Experience from Vojvodina, Serbia. Ind J Hematol Blood Transfus. 2016;32(2):208-14.